IMARC Group, a leading market research company, has recently releases report titled “Left Atrial Appendage Closure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global left atrial appendage closure devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the left atrial appendage closure devices market?
The global left atrial appendage closure devices market size reached US$ 1.23 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.83 Billion by 2028, exhibiting a growth rate (CAGR) of 19.3 % during 2023-2028.
What is left atrial appendage closure devices?
Left atrial appendage closure (LAAC) devices are inserted in the heart to lower the chances of stroke in non-valvular atrial fibrillation (AFib) patients. The left atrial appendage (LAA) is a small pouch-like structure in the heart muscle that can be a source of blood clots resulting in stroke in AFib patients. LAAC devices are placed to permanently obstruct the LAA, prevent blood clots from forming, and lower the risk of stroke. They are inserted through minimally invasive (MI) procedures, including inserting a catheter through a small incision in the arm or groin. As a result, LAAC devices are widely employed in hospitals and ambulatory surgery centers across the globe.
Request for a free sample copy of this report: https://www.imarcgroup.com/left-atrial-appendage-closure-devices-market/requestsample
What are the growth prospects and trends in the left atrial appendage closure devices?
The market is primarily driven by the growing prevalence of atrial fibrillation. In addition, the rising consumption of high-calorie diets, smoking, and sedentary lifestyles of working professionals are contributing to market growth. In line with this, the expanding healthcare infrastructure and the surging need for advanced technological solutions are accelerating the product adoption rate. Moreover, numerous technological advancements in closure devices with improved safety and efficacy of the product and the increasing focus on developing minimally invasive (MI) devices to lower recovery time and enhance patient comfort represents another major growth-inducing factor. Besides this, the growing geriatric population susceptible to cardiovascular diseases (CVDs) and increased awareness of alternative treatment options are influencing the market growth. Furthermore, the introduction of electrophysiology procedures, the adoption of robotic-assisted closure devices, and extensive research and development (R&D) activities among key players are creating a positive market outlook.
What is included in market segmentation?
The report has segmented the market into the following categories:
Product Insights:
- Endocardial LAA Devices
- Epicardial LAA Devices
End User Insights:
- Hospitals
- Ambulatory Surgery Centers
- Others
Breakup by Geography:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- AtriCure Inc.
- Boston Scientific Corporation
- Cardia Inc.
- Lepu Medical Technology (Beijing) Co. Ltd.
- LifeTech Scientific
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=7138&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/